hsa-mir-573: Hsa-mir-573 is a microRNA that has been studied in breast cancer cells [PMC4381608]. In a comparison between SUM149PT and MCF-7 transfected breast cancer cells, it was found that the mRNA levels of pro-angiogenic factors VEGFA and ANGPT2 were reduced only in BRCA1 deficient cells transfected with hsa-mir-573 mimic [PMC4381608]. Additionally, it was discovered that elevated expression levels of hsa-mir-573 were significantly associated with improved disease-specific survival (DSS) in BRCA patients [PMC9428000]. This finding suggests that hsa-mir-573 may play a role in the prognosis of BRCA patients. References: [PMC4381608] - Liu, Y., Liu, R., Yang, F., Cheng, R., Chen, X., Cui, S. et al. (2015). miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Molecular Cancer 14(1), 14. [PMC9428000] - Chen YH et al. (2021). Identification of microRNA signature associated with prognosis and survival in patients with breast cancer by bioinformatics analysis. World Journal of Surgical Oncology 19(1), 201.